Evidence map›Paper›PMID 40787530›Full record

ReviewAnnals of medicine and surgery (2012)2025

Innovative approaches to vector control: integrating genomic, biological, and chemical strategies.

Ebrahim Abbasi

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. A Review of the Changing Global Impact of Arthropod-Borne Virus Diseases and Recent Initiatives from the World Health Organization.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ebrahim AbbasiResearch Center for Health Sciences, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0003-1861-5321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vector-borne diseases (VBDs) remain a significant global public health challenge, disproportionately affecting low- and middle-income countries. Traditional vector control methods, particularly chemical insecticides, face increasing limitations due to the rapid evolution of resistance and environmental concerns. Materials and methods: This review explores recent advancements in vector control, focusing on the integration of genomic, biological, and chemical strategies as innovative solutions to address these challenges. These methods include genomic tools such as CRISPR/Cas9-mediated systems, biological interventions like Wolbachia-based strategies and sterile insect techniques (SIT), and chemical innovations involving insecticides with novel modes of action and advanced delivery systems. Results: Genomic strategies like CRISPR/Cas9 gene drives show significant potential for precisely targeting vector reproduction and pathogen spread but face ecological and ethical hurdles to widespread use. Successful biological interventions, such as Wolbachia and SIT, have proven effective in reducing vector populations, yet they demand strong community involvement and ongoing funding for scalability. Additionally, innovative chemical solutions, including new insecticides and delivery methods, tackle resistance issues while reducing environmental harm, with techniques like microencapsulation and synergists improving sustainability. Discussion: This review highlights the importance of Integrated Vector Management (IVM) frameworks that combine genomic, biological, and chemical strategies. These integrated approaches maximize synergies while mitigating the limitations of individual methods. Key findings emphasize the potential of integrated approaches to achieve sustainable reductions in vector populations and disease transmission. However, significant challenges remain, including the need for standardized protocols, long-term effectiveness data, and considerations of ecological risks and climate change impacts.

Indexed as

biological interventionschemical innovationsCRISPR/Cas9genomic strategiesintegrated vector managementresistancevector-borne diseasesWolbachia

Identifiers

PMID40787530
PMCPMC12333756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.